Verily, a company backed by Google, announced this week that its Study Watch is labeled as a Class II medical device after receiving FDA approval for ECG readings.
In other words, its limited watch, which is only offered to customers based on a prescription, offers electrocardiogram support as well, being able to detect a series of heart diseases like atrial fibrillation.
“The FDA-cleared Study Watch is a prescription-only device intended to record, store, transfer and display single-channel ECG rhythms, and is indicated for use by healthcare professionals, adult patients with known or suspected heart conditions and health conscious individuals. The ability to take an on-demand, single-lead ECG, can support both population-based research and an individu… (read more)
Source link
Remember to like our Facebook and follow us on Twitter @iOSMode for a chance to win a free iPad Pro every month!
Quick Links: Download iPhone & iPad Wallpapers | Download iOS Games | Download iOS Apps